NERA Report Shows Continued Focus of Plaintiffs’ Securities Bar on the Pharmaceutical Industry (JSON)

lexblog.com/lib/AF2Y5G25view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "NERA Report Shows Continued Focus of Plaintiffs’ Securities Bar on the Pharmaceutical Industry",
    "url": "https://www.lexblog.com/2019/02/01/nera-report-shows-continued-focus-of-plaintiffs-securities-bar-on-the-pharmaceutical-industry/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-AF2Y5G25",
        "url": "https://www.lexblog.com/lib/AF2Y5G25/"
    },
    "datePublished": "2019-02-01T10:03:00-05:00",
    "dateModified": "2021-11-08T09:45:06-05:00",
    "author": {
        "@type": "Person",
        "name": "Gregg Weiner, Adam Harris, Abraham Lee"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Ropes & Gray"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Life Sciences Securities Litigation",
    "about": "Banking, Finance and Securities",
    "sourceUrl": "http://lifescienceslitigation.ropesgrayblogs.com/?p=1965",
    "sourceStability": "may-move"
}